| 1. |
慢性阻塞性肺疾病急性加重 (AECOPD) 診治專家組. 慢性阻塞性肺疾病急性加重 (AECOPD) 診治中國專家共識 (2017 年修訂版). 國際呼吸雜志, 2017, 37(14): 1041-1057.
|
| 2. |
Edwards L, Perrin K, Wijesinghe M, et al. The value of the CRB65 score to predict mortality in exacerbations of COPD requiring hospital admission. Respirology, 2011, 16(4): 625-629.
|
| 3. |
Global Initiative for Chronic Obstructive Lung Disease(GOLD): Global Strategy for the Diagnosis, Management and Prevention of Chronic Pulmonary Disease(2017 REPORT). http://www.goldcopd.org.
|
| 4. |
Hennemann G, Krenning EP. The kinetics of thyroid hormone transporters and their role in non-thyroidal illness and starvation. Best Pract Res Clin Endocrino Metab, 2007, 21(2): 323-338.
|
| 5. |
Plikat K, Langgartner J, Buettner R,et al. Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism, 2007, 56(2): 239-244.
|
| 6. |
Sahana PK, Ghosh A, Mukhopadhyay P, et al. A study on endocrine changes in patients in intensive care unit[J]. J Indian Med Assoc, 2008, 106(6): 362-364.
|
| 7. |
Adler SM, Wartofsky L. The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am, 2007, 36(3): 657-672.
|
| 8. |
高緒文, 李繼蓮. 甲狀腺疾病. 北京: 人民衛生出版社, 1999, 157-158.
|
| 9. |
俞春娟, 和明麗, 王俊軍, 等. 慢性阻塞性肺疾病急性加重期低 T3 綜合征及其臨床意義. 上海醫藥, 2014, 35(17): 34-37.
|
| 10. |
程洋, 戴麗, 夏國光. 慢性阻塞性肺疾病急性加重患者血清甲狀腺激素水平變化及臨床意義. 中華結核和呼吸雜志, 2016, 39 (12): 939-943.
|
| 11. |
程洋, 戴麗, 張運劍, 等. 慢性阻塞性肺疾病急性加重期患者血清甲狀腺激素水平與疾病嚴重程度的相關性. 中國醫藥, 2017, 12(6): 855-857.
|
| 12. |
周清, 吳琦. 老年 COPD 患者肺功能與血清甲狀腺激素的相關性分析. 山東醫藥, 2012, 52(12): 92-94.
|
| 13. |
羅潔, 王德明. 非甲狀腺疾病綜合征對危重癥患者的影響. 中國實用醫藥, 2010, 5(36): 247-248.
|
| 14. |
吳紅花, 高燕明. 老年病與正常甲狀腺病態綜合征. 中華老年多器官疾病雜志, 2011, 10(6): 570-572.
|
| 15. |
余松林. 醫學統計學. 北京: 人民衛生出版社, 2002, 164-178.
|